Simulect
NDC 0078-0331 · Novartis Pharmaceuticals Corporation
Generic namebasiliximab
Dosage formINJECTION, POWDER, FOR SOLUTION
RouteINTRAVENOUS
Active ingredient(s)BASILIXIMAB
Strength20 mg/5mL
Pharmacologic classInterleukin 2 Receptor Antagonists [MoA], Interleukin 2 Receptor-directed Antibody Interactions [MoA], Interleukin-2 Receptor Blocking Antibody [EPC]
Marketing categoryBLA
Packages
0078-0331-84 — 1 VIAL, SINGLE-USE in 1 CARTON (0078-0331-84) / 5 mL in 1 VIAL, SINGLE-USE
Billed under HCPCS
J0480 — Injection, basiliximab, 20 mg Medicare Part B payment limit (ASP + 6%): $4905.05
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0078-0393 — basiliximab